Antimicrobial susceptibility of strains of Propionibacterium acnes isolated from inflammatory acne

Revista Latinoamericana de Microbiologia

Volumn 48, Issue 1, 2006, Pages 14-16

  Gübelin, Walter ^a,b   Martínez, M Angélica ^a,d   Molina, M Teresa ^a   Zapata, Solange ^a   Valenzuela, M Eugenia ^c  

^a UNIVERSITY OF CHILE   (Chile)

^b UNIVERSIDAD DE LOS ANDES   (Chile)

^c National Health Institute of Chile

^d Departamento 403   (Chile)

Author keywords

Antimicrobial susceptibility; Inflammatory acne; Propionibacterium acnes

Indexed keywords

CLINDAMYCIN; DOXYCYCLINE; ERYTHROMYCIN; LYMECYCLINE; MINOCYCLINE; NADIFLOXACIN; PENICILLIN G; TETRACYCLINE; ANTIINFECTIVE AGENT;

ACNE; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIUM ISOLATE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; NONHUMAN; PROPIONIBACTERIUM ACNES; ACNE VULGARIS; BACTERIAL INFECTION; CLASSIFICATION; DRUG EFFECT; DRUG RESISTANCE; ISOLATION AND PURIFICATION; MICROBIOLOGY; MULTIDRUG RESISTANCE;

PROPIONIBACTERIUM ACNES;

ACNE VULGARIS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE; DRUG RESISTANCE, MULTIPLE, BACTERIAL; GRAM-POSITIVE BACTERIAL INFECTIONS; HUMANS; PROPIONIBACTERIUM ACNES;

EID: 34249679758     PISSN: 01874640     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Bojar, RA. & K.T. Holland. Acne and Propionibacterium acnes. Clin Dermatol 2004;22:375-9.
2. Brook, I. & E.H. Frazier. Infections caused by Propionibacterium species. Rev Infect Dis 1991;13:819-22.
3. Jakab, E., R. Zbinden, J. Gubler, C. Ruef, A. Von Graevenitz & M. Krause. Severe infections caused by Propionibacterium acnes: an underestimated pathogen in late postoperative infections. Yale J Biol Med 1996;69:477-82.
4. Jappe, U. Pathological mechanisms of acne with special emphasis on Propionibacterium acnes and related therapy. Acta Derm Venereol 2003;83:241-8.
5. Gupta, M.A. & A.K. Gupta. Depression and suicidal ideation in dermatology patients with acne, alopecia areata, atopic dermatitis and psoriasis. Br J Dermatol 1998;139:846-50.
6. Dreno, B., A. Reynaud, D. Moyse, H. Habert & H. Richet. Erythromycin-resistance of cutaneous bacterial flora in acne. Eur J Dermatol 2001;11:549-53.
7. Eady, E.A., M. Gloor & J.J. Leyden. Propionibacterium acnes resistance: a worldwide problem. Dermatology 2003;206:54-6.
8. Ross, J.I., A.M. Snelling, E. Carnegie, P.Coates, W.J. Cunliffe, V. Bettoli, G. Tosti, A. Akatsambas, J.I. Galvan Peréz del Pulgar, O. Rollman, L. Török, E.A. Eady & J.H. Cove. Antibiotic-resistant acne: lessons from Europe. Br J Dermatol 2003;148:467-78.
9. National Committee for Clinical Laboratory Standards. Methods for Antimicrobial Susceptibility Testing of Anaerobic Bacteria-Sixth Edition: Approved Standard M11-A6. NCCLS, Wayne, Pennsylvania, USA, 2004.
10. Akamatsu, H., H. Sasaki, I. Kurokawa, S. Nishijiima, Y. Asada & Y. Niwa. Effect of nadifloxacin on neutrophil functions. J Int Med Res 1995;23:19-26.
11. Grosshans, E., S. Belaich, J. Meynadier, M. Alirezai & L. Thomas. Comparison of the efficacy and safety of lymecycline and minocycline in patients with moderately severe acne vulgaris. Eur J Dermatol 1998; 8: 161-6.
12. Yamakawa, T., J. Mitsuyama & K. Hagashi. In vitro and in vivo antibacterial activity of T-3912, a novel non-fluorinated topical quinolone. J Antimicrob Chemother 2002;49:455-65.